PRESS RELEASE published on 05/05/2025 at 22:30, 1 year 6 months ago DBV Technologies participera à la conférence Citizens JMP Life Sciences DBV Technologies participera à la conférence Citizens JMP Life Sciences à New York le 7 mai 2025. Daniel Tassé, Directeur Général, prendra part à un discussion. La webdiffusion en direct sera disponible sur le site de l'entreprise. DBV se concentre sur le traitement des allergies alimentaires Life Sciences Investisseurs Conference DBV Technologies Allergies Alimentaires
PRESS RELEASE published on 05/05/2025 at 22:30, 1 year 6 months ago DBV Technologies to Participate in the Citizens JMP Life Sciences Conference DBV Technologies CEO to speak at Citizens JMP Life Sciences Conference in NY. Company develops treatments for food allergies with VIASKIN patch technology DBV Technologies Food Allergies VIASKIN Patch Life Sciences Conference Citizens JMP
BRIEF published on 04/15/2025 at 14:16, 1 year 6 months ago Franchissement de seuils par Baker Bros Advisors chez DBV Technologies Franchissement De Seuil Augmentation De Capital Bons De Souscription DBV Technologies Baker Bros Advisors
BRIEF published on 04/15/2025 at 14:16, 1 year 6 months ago Baker Bros Advisors Crosses Thresholds at DBV Technologies Warrants Capital Increase Threshold Crossing DBV Technologies Baker Bros Advisors
BRIEF published on 04/15/2025 at 14:13, 1 year 6 months ago Franchissement de seuils par JP Morgan Chase & Co. dans DBV Technologies Marché Financier Franchissement De Seuil DBV Technologies JP Morgan Chase & Co. Actions Et Droits De Vote
BRIEF published on 04/15/2025 at 14:13, 1 year 6 months ago JP Morgan Chase & Co. Crosses Thresholds in DBV Technologies Financial Market Threshold Crossing Shares And Voting Rights DBV Technologies JP Morgan Chase & Co.
PRESS RELEASE published on 04/15/2025 at 14:11, 1 year 6 months ago Franchissement de seuils Déclaration de franchissement de seuils de la société DBV Technologies par Baker Bros Advisors, L.P. pour le compte de fonds sous gestion AMF Franchissement De Seuils Fonds Sous Gestion DBV Technologies Baker Bros Advisors
PRESS RELEASE published on 04/15/2025 at 14:08, 1 year 6 months ago Franchissement de seuils Déclaration de franchissement de seuils pour DBV Technologies par JP Morgan Chase & Co. le 9 avril 2025 Capital AMF Franchissement De Seuils DBV Technologies JP Morgan Chase & Co.
BRIEF published on 04/11/2025 at 22:35, 1 year 6 months ago DBV Technologies publie ses rapports financiers annuels Document D'Enregistrement Universel Form 10-K DBV Technologies Société Biopharmaceutique États Financiers 2024
BRIEF published on 04/11/2025 at 22:35, 1 year 6 months ago DBV Technologies Releases Annual Financial Reports Biopharmaceutical Company Universal Registration Document Form 10-K DBV Technologies 2024 Financial Statements
Published on 11/09/2026 at 14:15, 1 hour 9 minutes ago Jericho Energy Ventures to Participate in Cantor Convergence 4th Annual Crypto and AI Infrastructure Conference
Published on 11/09/2026 at 14:00, 1 hour 24 minutes ago Tectonic Metals Adds Mine Development and Alaska Native Partnership Leaders Ahead of 2027 Mineral Resource Estimate and Preliminary Economic Assessment
Published on 11/09/2026 at 15:05, 18 minutes ago DIVEROID's WatchDive Turns Everyday Smartwatches into Dive Computers, Launching on Kickstarter in December
Published on 11/09/2026 at 15:05, 18 minutes ago Harley-Davidson Selects Horizon Global as Growth Partner
Published on 11/09/2026 at 15:00, 23 minutes ago PhotonPay Strengthens North American Regulatory Footprint with Canada's RPAA Registration
Published on 11/09/2026 at 14:54, 29 minutes ago Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 11/09/2026 at 10:32, 4 hours 52 minutes ago Disclosure of shares outstanding and voting rights - 09.11.2026
Published on 11/09/2026 at 10:32, 4 hours 52 minutes ago Déclaration nombre d'actions et droits de vote - 09.11.2026
Published on 11/09/2026 at 07:00, 8 hours 24 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 8 hours 24 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
